Philip G. Conaghan

University of Leeds

Papers

1

Total Citations

2

H-Index

1

About

Philip G. Conaghan is a leading rheumatologist and researcher whose work has fundamentally shaped the understanding and management of osteoarthritis (OA). His key research areas include the structural progression of OA, the development of novel imaging biomarkers, and the design of innovative clinical trials for pain and joint disease. A major contribution has been his leadership in the IMI-APPROACH study, which demonstrated that 3D bone shape from CT scans provides an objective, sensitive measure of OA severity—a breakthrough that could transform decisions for total knee arthroplasty by moving beyond subjective pain reports and unreliable radiographs. With over 500 publications and more than 30,000 citations, Conaghan’s impact is profound. He has also been instrumental in developing the OMERACT core outcome set for OA trials, ensuring standardized, patient-relevant endpoints. His work bridges imaging science and clinical practice, offering a more precise path to diagnosing and treating this debilitating disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
3D bone shape from CT-scans provides an objective measure of osteoarthritis severity: Data from the IMI-APPROACH study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: University of Leeds

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago